Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nicotinic acid 250 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing nicotinic acid and simvastatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Nicotinic acid and simvastatin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Niacin intake |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
Nicotinic acid 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Nicotinic acid 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Poisoning by nicotinic acid (disorder) |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Accidental poisoning by nicotinic acid |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Intentional poisoning by nicotinic acid (disorder) |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Accidental nicotinic acid overdose (disorder) |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Nicotinic acid overdose (disorder) |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Intentional nicotinic acid overdose |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
The approximate quantity of intake in one day of niacin. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
3 |
Measured quantity of intake of niacin in 24 hours |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
5 |
Estimated quantity of niacin needed for nutritional adequacy in one day. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
4 |
Nicotinic acid 375 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Nicotinic acid 375 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
The approximate quantity of intake in one day of niacin. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
3 |
Measured quantity of intake of niacin in 24 hours |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
5 |
Niacin intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
Estimated quantity of niacin needed for nutritional adequacy in one day. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Some |
4 |
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only calcium gluconate and colecalciferol and nicotinic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing calcium gluconate and colecalciferol and nicotinic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only calcium gluconate and colecalciferol and nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
Calcium gluconate- and colecalciferol- and nicotinic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
2 |
The approximate quantity of intake in one day of niacin. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Estimated quantity of niacin needed for nutritional adequacy in one day. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Niacin intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Measured quantity of intake of niacin in 24 hours |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |
Serum nicotinic acid measurement (procedure) |
Component |
True |
Nicotinic acid (substance) |
Inferred relationship |
Some |
1 |